Enterococcus faecium CRL183
Enterococcus faecium CRL183 is a Brazilian research strain with a body of primarily in vitro and animal evidence. Laboratory studies have examined cholesterol removal capacity in culture media, inhibition of Candida albicans biofilms, and use in fermented meat products; animal experiments in hypercholesterolemic rabbits examined lipid-related outcomes when the strain was combined with isoflavones, though rabbit models do not directly translate to human outcomes. The strain has been formulated into lozenges and orodispersible films for exploratory oral health research. The Enterococcus genus includes opportunistic pathogens, and E. faecium strains require careful safety profiling; the evidence base for CRL183 is modest and largely preclinical. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 7 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 5 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
11 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.